Suchergebnisse - "Jouzeau, Jean-Yves"

PubPharm (6)

1

Gastroenterological safety of IL-17 inhibitors : a systematic literature review

enthalten in: Expert opinion on drug safety | 2022

von Caron, B. | Jouzeau, J. | Miossec, P. | +4

2

IL-17 Inhibitors and Inflammatory Bowel Diseases : A Postmarketing Study in Vigibase

enthalten in: Clinical pharmacology and therapeutics | 2021

von Petitpain, N. | D'Amico, F. | Yelehe-Okouma, M. | +4

3

Paradoxical gastrointestinal effects of interleukin-17 blockers

enthalten in: Annals of the rheumatic diseases | 2020

von Fauny, M. | Moulin, D. | D'Amico, F. | +6

CommentIn: Ann Rheum Dis. 2023 Jun;82(6):e152. - PMID 32988844

4

The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway

enthalten in: Arthritis and rheumatism | 2013

von Koufany, M. | Chappard, D. | Netter, P. | +4

5

Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis

enthalten in: The Journal of rheumatology | 2002

von Pacquelet, S. | Presle, N. | Boileau, C. | +6

6

Nitric oxide (NO) and cartilage metabolism : NO effects are modulated by superoxide in response to IL-1

enthalten in: Biorheology | 2002

von Jouzeau, J. | Pacquelet, S. | Boileau, C. | +4

1
[1]